ENDPOINTS

Aura’s bladder cancer data; Poseida discloses $15M milestone from Roche

8 months ago

News Briefing

Viatris, Lexicon ink licensing deal; Capricor’s $75M offering

8 months ago

News Briefing

Exscientia’s $15M milestone from Sanofi; Lilly to take Gateway Labs to China

8 months ago

News Briefing

Cycle makes another offer for Vanda; Ocean Biomedical, Molecure ink new deal

8 months ago

News Briefing

Akeso raises $250M; SalioGen’s layoffs

8 months ago

News Briefing

Ono’s ADC deal; Leo Pharma to conduct layoffs

9 months ago

News Briefing

Crinetics’ $500M offering; Boehringer inks deal with macrocycles biotech

9 months ago

News Briefing

Scholar Rock aims to raise $275M; Vincerx to reshuffle pipeline focus

9 months ago

News Briefing

Special report 2024: Meet 20 women breaking new ground in biopharma R&D

9 months ago

Special

Galapagos investor gets board seat; OnKure completes merger with Reneo

9 months ago

News Briefing

Editas sells future CRISPR license fees; Plus, news about Oncolytics Biotech

9 months ago

News Briefing

FDA lifts partial hold on Avidity’s myotonic dystrophy drug; Orum's IPO in South Korea

9 months ago

News Briefing

Biohaven aims to raise $250M; Activist investor's stake in Galapagos exceeds 10%

9 months ago

News Briefing

Repair, Genevant ink deal worth up to $107M; 858 Therapeutics raises $50M

9 months ago

News Briefing

Corrected: Sanofi inks deal with I-Mab spinout; Wave discloses $175M offering on heels of DMD data

9 months ago

News Briefing

Capricor to begin filing DMD drug with FDA next month; Surrozen’s $10M milestone

9 months ago

News Briefing

Context makes a T cell engager deal; Ginkgo Bioworks backers have a new SPAC

9 months ago

News Briefing

Ascendis aims to raise $300M; Basilea inks up to $268M deal with BARDA

9 months ago

News Briefing

Capricor expands DMD pact with Nippon Shinyaku; AbbVie’s new eye deal

9 months ago

News Briefing

Nuvalent's $350M offering; FDA lifts partial hold on Zentalis drug

9 months ago

News Briefing

GSK’s mRNA flu shot is heading to Phase 3; Summit’s $235M offering

10 months ago

News Briefing

Immunovant shares mid-stage Graves’ disease data; FDA lifts Rezolute’s hold

10 months ago

News Briefing

Basilea records $25M milestone; Connect Biopharma reduces workforce in China

10 months ago

News Briefing

Novartis pays $15M upfront to license Voyager program; Boehringer advances geographic atrophy drug

10 months ago

News Briefing

about the author

author articles

Aura’s bladder cancer data; Poseida discloses $15M milestone from Roche

Viatris, Lexicon ink licensing deal; Capricor’s $75M offering

Exscientia’s $15M milestone from Sanofi; Lilly to take Gateway Labs to China

Cycle makes another offer for Vanda; Ocean Biomedical, Molecure ink new deal

Akeso raises $250M; SalioGen’s layoffs

Ono’s ADC deal; Leo Pharma to conduct layoffs

Crinetics’ $500M offering; Boehringer inks deal with macrocycles biotech

Scholar Rock aims to raise $275M; Vincerx to reshuffle pipeline focus

Special report 2024: Meet 20 women breaking new ground in biopharma R&D

Galapagos investor gets board seat; OnKure completes merger with Reneo

Editas sells future CRISPR license fees; Plus, news about Oncolytics Biotech

FDA lifts partial hold on Avidity’s myotonic dystrophy drug; Orum's IPO in South Korea

Biohaven aims to raise $250M; Activist investor's stake in Galapagos exceeds 10%

Repair, Genevant ink deal worth up to $107M; 858 Therapeutics raises $50M

Corrected: Sanofi inks deal with I-Mab spinout; Wave discloses $175M offering on heels of DMD data

Capricor to begin filing DMD drug with FDA next month; Surrozen’s $10M milestone

Context makes a T cell engager deal; Ginkgo Bioworks backers have a new SPAC

Ascendis aims to raise $300M; Basilea inks up to $268M deal with BARDA

Capricor expands DMD pact with Nippon Shinyaku; AbbVie’s new eye deal

Nuvalent's $350M offering; FDA lifts partial hold on Zentalis drug

GSK’s mRNA flu shot is heading to Phase 3; Summit’s $235M offering

Immunovant shares mid-stage Graves’ disease data; FDA lifts Rezolute’s hold

Basilea records $25M milestone; Connect Biopharma reduces workforce in China

Novartis pays $15M upfront to license Voyager program; Boehringer advances geographic atrophy drug